Treatment of inflammatory disorders
The present disclosure provides compounds and methods of use thereof for treating inflammatory diseases or disorders.
1. A method of treating a disease, disorder, or condition, comprising administering to a subject in need thereof an effective amount of the following compound:
or a pharmaceutically acceptable salt thereof;
wherein the disease, disorder, or condition is inflammatory bowel disease (IBD), Crohn's disease, ulcerative colitis (UC), IBS (irritable bowel syndrome), or spastic colon.
2. The method according to claim 1 , wherein the disease, disorder, or condition is inflammatory bowel disease (IBD).
3. The method according to claim 1 , wherein the disease, disorder, or condition is Crohn's disease.
4. The method according to claim 1 , wherein the disease, disorder, or condition is ulcerative colitis (UC).
5. The method according to claim 1 , wherein the disease, disorder, or condition is IBS (irritable bowel syndrome) or spastic colon.
6. The method according to claim 1 , wherein the compound or pharmaceutically acceptable salt thereof is administered systemically to the subject.
7. The method according to claim 1 , wherein the compound or pharmaceutically acceptable salt thereof is administered orally to the subject.